Litcius/Paper detail

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor exerts greater efficacy than atorvastatin on improvement of brain function and cognition in obese rats

Busarin Arunsak, Wasana Pratchayasakul, Patchareeya Amput, Kenneth Chattipakorn, Theetouch Tosukhowong, Sasiwan Kerdphoo, Thidarat Jaiwongkum, Chanisa Thonusin, Siripong Palee, Nipon Chattipakorn, Siriporn C. Chattipakorn

2020Archives of Biochemistry and Biophysics19 citationsDOI

Topics & Concepts

PCSK9KexinAtorvastatinEndocrinologyInternal medicineProprotein convertaseMedicineCognitive declinePharmacologyLipoproteinCholesterolLDL receptorDementiaDiseaseLipoproteins and Cardiovascular HealthComputational Drug Discovery MethodsHormonal Regulation and Hypertension
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor exerts greater efficacy than atorvastatin on improvement of brain function and cognition in obese rats | Litcius